NCT03401606

Controlled Sedation for Cataract Surgery

Dexmedetomidine vs. Remifentanil for Patient and Surgeon Satisfaction in Cataract Surgery Under Controlled Sedation

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 98 (actual)
• Sponsor: Fundación Universitaria de Ciencias de la Salud · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study evaluates the surgeon and patient´s satisfaction who undergoes cataract surgery using either dexmedetomidine or remifentanil as sedation

Detailed description

This is a double blind, randomized study which evaluates surgeon and patient´s satisfaction whom undergoes cataract surgery. The surgery was done under local anesthesia and sedation.

Conditions

• Failed Conscious Sedation During Procedure

Interventions

Type	Name	Description
DRUG	remifentanil	remifentanil, 0.25 ng/mL, given intravenous, infusion, until surgery finished
DRUG	Dexmedetomidine	dexmedetomidine, 0.125 mcg/kg/hour, given intravenous, infusion, until surgery finished

Timeline

• Start date: 2014-11-01
• Primary completion: 2015-10-30
• Completion: 2016-01-30
• First posted: 2018-01-17
• Last updated: 2018-01-17